Literature DB >> 23064543

Markers of acute neuropsychiatric systemic lupus erythematosus: a multidisciplinary evaluation.

Essam A Abda1, Zahraa I Selim, Moustafa E M Radwan, Nagham M Mahmoud, Omar M Herdan, Khalid A Mohamad, Sherifa A Hamed.   

Abstract

This study was aimed to assess: (1) the additive diagnostic utility of diffusion-weighted imaging (DWI) and magnetic resonance angiography (MRA) over conventional MRI in detecting brain lesions in patients with acute primary neuropsychiatric systemic lupus erythematosus (NPSLE), and (2) the relevance of their findings to the associated NP manifestations. Included were 34 patients with acute NPSLE with mean age of 33.26 ± 10.14 years and duration of illness of 3.33 ± 1.71 years. Clinical interviewing and psychiatric and cognitive evaluations were performed by applying the criteria of the diagnostic and statistical manual of mental health disorders criteria (DSM-IV), Stanford Binet Subset Testing, Mini-Mental State Examination and Wechsler Memory Scale-Revised. Serologic tests included looking for antinuclear antibodies, anti-double strand DNA, anti-phospholipid antibodies. Radiologic evaluation included conventional MRI, DWI and MRA. One or more NP manifestations were diagnosed in 28 patients, in which cognitive deficits were reported with headache, psychosis and CVS. Anti-phospholipid antibodies were reported in patients with CVS. Twenty patients (71.43 %) with primary NPSLE (n = 28) had MRI abnormalities in which hyperintense signals at subcortical and periventricular white matter and at the junction between the gray and white matter represented 75 % (n = 15) and with headache (n = 6), psychosis (n = 6) and acute confusional state (n = 3) with and without cognitive deficits, respectively. Moderate-sized infarctions with restricted diffusion in the distribution of middle cerebral arteries were represented in 35 % (n = 7) and with CVS, of them, 71.43 % (n = 5) had beading and focal narrowing of carotid arteries were consistent with vasculitis. Brain atrophy represented 20 % (n = 4) and with psychosis. Compared to those with normal MRI, patients with MRI abnormalities were older (P < 0.050) and had longer duration of illness (P < 0.050). To conclude, although DWI and MRA are helping in more precise etiopathologic diagnosis compared to conventional MRI, but their relevance to the present NP manifestations is still limited.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23064543     DOI: 10.1007/s00296-012-2531-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  44 in total

1.  Magnetic resonance imaging in the evaluation of patients with aseptic meningoencephalitis and connective tissue disorders.

Authors:  S Appenzeller; E Kobayashi; L T Costallat; V D Zanardi; J M Ribeiro Neto; B P Damasceno; F Cendes
Journal:  Arq Neuropsiquiatr       Date:  2000-03       Impact factor: 1.420

2.  "Subcortical" cognitive impairment in patients with systemic lupus erythematosus.

Authors:  E Leritz; J Brandt; M Minor; F Reis-Jensen; M Petri
Journal:  J Int Neuropsychol Soc       Date:  2000-11       Impact factor: 2.892

3.  Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus.

Authors:  Simone Appenzeller; Leonardo Bonilha; Pablo A Rio; Li Min Li; Lilan Tereza Lavras Costallat; Fernando Cendes
Journal:  Neuroimage       Date:  2006-11-16       Impact factor: 6.556

4.  Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning.

Authors:  W J McCune; A MacGuire; A Aisen; S Gebarski
Journal:  Arthritis Rheum       Date:  1988-02

5.  The role of endothelial dysfunction in the pathogenesis of neuropsychiatric systemic lupus erythematosus.

Authors:  R Davey; J Bamford; P Emery
Journal:  Lupus       Date:  2010-01-29       Impact factor: 2.911

Review 6.  Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden.

Authors:  N Danchenko; J A Satia; M S Anthony
Journal:  Lupus       Date:  2006       Impact factor: 2.911

7.  Asymptomatic cerebrovascular lesions detected by magnetic resonance imaging in patients with systemic lupus erythematosus lacking a history of neuropsychiatric events.

Authors:  K Nomura; S Yamano; Y Ikeda; H Yamada; T Fujimoto; S Minami; R Fukui; M Takaoka; Y Yamamoto; K Dohi
Journal:  Intern Med       Date:  1999-10       Impact factor: 1.271

8.  Assessment of biocorrelates for brain involvement in female patients with rheumatoid arthritis.

Authors:  Sherifa A Hamed; Zahra I Selim; Amal M Elattar; Yasser M Elserogy; Eman A Ahmed; Hanan O Mohamed
Journal:  Clin Rheumatol       Date:  2011-06-22       Impact factor: 2.980

9.  Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus.

Authors:  R J Chinn; I D Wilkinson; M A Hall-Craggs; M N Paley; E Shortall; S Carter; B E Kendall; D A Isenberg; S P Newman; M J Harrison
Journal:  Arthritis Rheum       Date:  1997-01

10.  Ethnic difference in the prevalence of systemic lupus erythematosus.

Authors:  H H Hart; R R Grigor; D E Caughey
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

View more
  9 in total

1.  Brain MRI in neuropsychiatric lupus: associations with the 1999 ACR case definitions.

Authors:  Hae Woong Jeong; Minyoung Her; Jong Seok Bae; Seong-Kyu Kim; Sung Won Lee; Ho Kyun Kim; Dongyook Kim; Nayoung Park; Won Tae Chung; Sang Yeob Lee; Jung-Yoon Choe; In Joo Kim
Journal:  Rheumatol Int       Date:  2014-10-15       Impact factor: 2.631

2.  Mycophenolate mofetil and deflazacort combination in neuropsychiatric lupus: a decade of experience from a tertiary care teaching hospital in southern India.

Authors:  Nikhil Gupta; Arvind Ganpati; Santosh Mandal; John Mathew; Ruchika Goel; Ashish Jacob Mathew; Aswin Nair; Prakash Ramasamy; Debashish Danda
Journal:  Clin Rheumatol       Date:  2017-08-07       Impact factor: 2.980

3.  Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus Erythematosus.

Authors:  B Cesar; M G Dwyer; J L Shucard; P Polak; N Bergsland; R H B Benedict; B Weinstock-Guttman; D W Shucard; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2015-06-11       Impact factor: 3.825

Review 4.  Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.

Authors:  Hélène Jeltsch-David; Sylviane Muller
Journal:  Nat Rev Neurol       Date:  2014-09-09       Impact factor: 42.937

5.  Brain magnetic resonance imaging, cerebrospinal fluid, and autoantibody profile in 118 patients with neuropsychiatric lupus.

Authors:  Zhen Tan; Yingbo Zhou; Xiangpei Li; Guosheng Wang; Jinhui Tao; Li Wang; Yan Ma; Xiaomei Li
Journal:  Clin Rheumatol       Date:  2017-11-04       Impact factor: 2.980

Review 6.  From Systemic Inflammation to Neuroinflammation: The Case of Neurolupus.

Authors:  Mykolas Bendorius; Chrystelle Po; Sylviane Muller; Hélène Jeltsch-David
Journal:  Int J Mol Sci       Date:  2018-11-13       Impact factor: 5.923

Review 7.  Advanced and Conventional Magnetic Resonance Imaging in Neuropsychiatric Lupus.

Authors:  Nicolae Sarbu; Núria Bargalló; Ricard Cervera
Journal:  F1000Res       Date:  2015-06-23

Review 8.  Cerebral Microstructure Analysis by Diffusion-Based MRI in Systemic Lupus Erythematosus: Lessons Learned and Research Directions.

Authors:  Ettore Silvagni; Alessandra Bortoluzzi; Massimo Borrelli; Andrea Bianchi; Enrico Fainardi; Marcello Govoni
Journal:  Brain Sci       Date:  2021-12-31

9.  Cognitive dysfunction and associated neuroimaging biomarkers in antiphospholipid syndrome: a systematic review.

Authors:  Claire Donnellan; Hannah Cohen; David J Werring
Journal:  Rheumatology (Oxford)       Date:  2021-12-24       Impact factor: 7.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.